In a nutshell The article evaluated the accuracy of YKL-40 levels to predict a patient’s response to chemotherapy for the treatment of SCLC and their cancer outcomes. Some background Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and has a low 5-year survival rate of 10-26% due to relapse (cancer...
Read MoreType(s) of chemotherapy-Irinotecan (Camptosar) Posts on Medivizor
Irinotecan or topotecan instead of etoposide for extensive small cell lung cancer
In a nutshell This trial investigated whether chemotherapy drugs belonging to the class of camptothecins (such as irinotecan or topotecan) used together with platinum analog chemotherapy (such as cisplatin or carboplatin) were better than the standard regimens in treating extensive disease small-cell lung cancer. Some background Standard treatment...
Read More